Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

hepatitis B virus antisense oligonucleotide AHB-137

An unconjugated antisense oligonucleotide (ASO) targeting human hepatitis B virus (HBV), with potential antiviral activity. Upon subcutaneous administration, HBV ASO AHB-137 targets and binds to HBV messenger RNA (mRNA), thereby inhibiting the translation of HBV viral proteins. This may inhibit HBV replication.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:HBV ASO AHB-137
Code name:AHB 137
AHB-137
AHB137
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search